NASDAQ:FENC
Fennec Pharmaceuticals Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Capital Marketwebsite
www.fennecpharma.comipo date
Jun 05, 2001full time employees
36currency
USD
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex T...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus